| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27241-239-01 | 27241-239 | HUMAN PRESCRIPTION DRUG | Oxcarbazepine | Oxcarbazepine | TABLET, EXTENDED RELEASE | ORAL | 20240222 | N/A | ANDA | ANDA217659 | Ajanta Pharma USA Inc. | OXCARBAZEPINE | 600 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-239-01) |
| 27241-238-01 | 27241-238 | HUMAN PRESCRIPTION DRUG | Oxcarbazepine | Oxcarbazepine | TABLET, EXTENDED RELEASE | ORAL | 20240222 | N/A | ANDA | ANDA217659 | Ajanta Pharma USA Inc. | OXCARBAZEPINE | 300 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-238-01) |
| 27241-237-01 | 27241-237 | HUMAN PRESCRIPTION DRUG | Oxcarbazepine | Oxcarbazepine | TABLET, EXTENDED RELEASE | ORAL | 20240222 | N/A | ANDA | ANDA217659 | Ajanta Pharma USA Inc. | OXCARBAZEPINE | 150 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-237-01) |